Anthracyclines, such as doxorubicin, and monoclonal antibodies, such as trastuzumab, are compounds of wide clinical use as cytotoxic chemotherapy as they. Cardiotoxicidad asociada a trastuzumab en la práctica clínica asistencial Neutropenia inducida por dosis terapéuticas de metronidazol intravenoso. cardiotoxicidad inducida por quimioterapia, además de hacer una síntesis de los diferentes . tion (anthracyclines, trastuzumab, tyrosine kinase inhibitors.
|Published (Last):||21 June 2008|
|PDF File Size:||12.54 Mb|
|ePub File Size:||8.90 Mb|
|Price:||Free* [*Free Regsitration Required]|
Utility of prechemotherapy echocardiographical assessment of cardiac abnormalities.
Curr Control Trials Cardiovasc Med. According to the study by Cintra et al 7the age range of patients with breast cancer with HER2 overexpression presents in two peaks 40 and 59 years and 70 years or older, which is consistent with the data collected in the study, caediotoxicidad demonstrating the predominance of invasive ductal histological type with Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. Currently, one of the major stakes in the treatment of cancer is immunotherapy, which consists of stimulation of the immune system through the use of substances modifying the biological response, which may occur through the result of the antigen-antibody interaction ;or the mechanisms involved in the mediated immunity by cells 5.
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure.
Jpn J Clin Oncol. Curr Treat Options Cardiovasc Med. Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Eletronic Journal of Pharmacy. Expert Rev Anticancer Ther. Intermitted pharmacologic pretreatment cardiotoxickdad xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells.
Sedentary behavior, physical activity, and the metabolic syndrome among U. The data were obtained through the analysis of the medical records of the patients attended at the outpatient clinic from January to December Cardiotoxiciead early changes in myocardial antioxidant enzymes and their modulation by probucol.
Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells.
There was a problem providing the content you requested
Anderson Cancer Center experience. Optimal management of emergent hypertension during treatment with a VEGF signaling inhibitor: Tabone MD, Leverger G. The role of endomyocardial biopsy in the management of cardiovascular disease: Cardiotoxicity of chemotherapeutic agents: Effect of a vigorous aerobic regimen on physical performance in breast cancer patients – a randomized controlled pilot trial. Cardiotoxicity associated with targeting kinase pathways in cancer.
Characteristics and outcomes of cardiotoxicidwd with cancer requiring admission to intensive care units: Cardiac toxicity from systemic cancer therapy: Anticancer drugs and cardiotoxicity: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. A maior parte dos pacientes que desenvolveu HAS durante o tratamento foi tratada com anti-hipertensivos e a terapia com trastuzumabe foi mantida.
Despite documented evidence of arrhythmias in both human and animal models, sudden cardiac death during or immediately after the infusion of chemotherapy is not well described.
Cardiac dysfunction in the trastuzumab clinical trials experience. Left ventricular dysfunction predicted by early cardiotoxifidad I release after high-dose chemotherapy. Crit Rev Oncol Hematol.
Muerte súbita debida a cardiotoxicidad aguda inducida por antraciclinas
Monoclonal antibodies, as target therapy, have high specificity with few side effects, being the focus of many research on diseases that require more aggressive treatment. Each drug class will act at a particular stage cardiotoxicjdad the cell cycle, not only acting on cancer cells, but also on normal cells of rapid proliferation. Cardiotoxicity of anticancer drugs: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.
Pathology of drug-eluting stents in humans: Guidelines for the management of antiplatelet therapy in patients with coronary stents undergoing non-cardiac surgery. Antineoplastic drug residues inside homes of chemotherapy patients. Introducing a new entity: Sudden death due to anthracycline-induced acute cardiotoxicity.
Benefits and adverse effects of endocrine therapy.